linkedin post 2013-01-14 15:25:37

Uncategorized
Mechanism of Action (MOA) questions in drug discovery quite often smack of either hubris (think complex world) or forgetfulness (think history). That humble approaches have quantitatively out-performed MOA approaches is reassuring, if that is that is the word, about our modest knowledge of how complex systems really work. http://lnkd.in/RT8Dyr View in LinkedIn
Read More

linkedin post 2013-01-14 05:41:23

Uncategorized
As the world shrinks, the Internet flattens it. It was rather revolutionary sone decade ago when MIT was among the first to put courses online. Then recently China declared an initiative to bring world class names to create brand new top universities in China from scratch. No 500 year traditions. This is an exciting and likely irreversible trend in education. http://lnkd.in/gAPXT5 View in LinkedIn
Read More

linkedin post 2013-01-06 14:38:48

Uncategorized
Fantastic start and so much in the right direction. The first real key is mentoring these young entrepreneurs. The second real key is follow-on funding. We say "Mind The Gap" in the UK underground. The same applies to some of the businesses that will be seeded by these vital funds. The higher value enterprises, that will create a lot of jobs, will be facing The Gap as they mature, and it appears obvious that tax incentives for investments of this sort are critical. This includes keeping a healthy Venture Capital incentive alive and well. http://lnkd.in/--ct3d View in LinkedIn
Read More

linkedin post 2013-01-13 08:48:35

Uncategorized
Age is not the innovator. Ideas are. Always will be. but ideas are cheap. implementation is not. That said, there is truth in the fact that earlier in life entrepreneurs may be less encumbered with family and other ties. By contrast, the older entrepreneur, especially the successful" "serial entrepreneur is emerging as a sought-after asset by some very smart VCs. http://lnkd.in/NS_vQT View in LinkedIn
Read More

linkedin post 2013-01-06 14:01:29

Uncategorized
This appears to be a move that recognizes the power of personalized medicine -- reduced patient heterogeneity, or a 'zero phase' clinical trial for drug screening, obviating the sometimes misleading results from animal models. Also, implicitly, the possibility of growing donor organs in a test tube. Awesome! http://lnkd.in/CXkW8P View in LinkedIn
Read More

linkedin post 2013-01-13 07:49:05

Uncategorized
The fast emerging blurring of the lines between traditional VC's roles in funding emerging companies, and the saucy developments in crowd-funding is presented in this compelling article. While crowd-funding typically has funded near-to-market ventures, will it blur further south to pre-product promising discovery funding? That is the high risk high return sweet spot that young tech companies find the most challenging to finance. Watch thus space! http://lnkd.in/gPCsNB View in LinkedIn
Read More

linkedin post 2013-01-13 07:13:36

Uncategorized
Looking for orthopedic strategy experts to consult (in English by videoconferencing) for an innovative and easily implanted Pectus Excavatum device to treat the condition. The company gets the CE Mark this summer, and is evaluating all possible options for trials in the US, and elsewhere, with or without a partner, and a rollout plan fir Europe. Located close to Barcelona. View in LinkedIn
Read More